Are diuretics helpful for migraines-associated vertigo?

Migraine pp 17-348 | Cite as


Instructions for using the IHS-ICHD-II codes listed below (Headache Classification Committee et al. 2004)

This is a preview of subscription content, log in to check access.


Unable to display preview. Download preview PDF.


  1. Afridi SK, Goadsby PJ (2006) Neuroimaging of migraine. Curr Pain Headache Rep 10 (3): 221-224 PubMedCrossRefGoogle Scholar
  2. Afridi SK, Matharu MS, et al. (2005) A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 128 (Pt 4): 932-939PubMedCrossRefGoogle Scholar
  3. AgostoniE, Fumagalli L et al. (2004) Migraine and stroke. Neurol Sci 25 (Suppl 3: S123-125PubMedCrossRefGoogle Scholar
  4. Ahonen K, Hamalainen ML et al. (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67 (7): 1135-1140 PubMedCrossRefGoogle Scholar
  5. Airi O, Erkintalo, et al. (2008) Neck muscles' cross-sectional area in adolescents with and without headache - MRI study. Eur J Pain 12 (7): 952-959 CrossRefGoogle Scholar
  6. Airy H (1870) On a distinct form of transient hemiopsia. PhilosTrans R Soc Lond160: 247–270CrossRefGoogle Scholar
  7. Amberbir A, Medhin G, Alem A, Britton J, Davey G, Venn A (2011) The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: A longitudinal birth-cohort study. Am J Respir Crit Care Med 183 (2): 165-170. Epub 2010 Oct 8. PubMed PMID: 20935107Google Scholar
  8. Andersen AR, Friberg HH, Schmidt JF, Hasselbalch SG (1988) Quantitative measurements of cerebral blood flow using SPECT and 99mTc-d, l-HM-PAO compared to xenon-133. J Cereb Blood Flow Metab 8 (6): S69-S81PubMedCrossRefGoogle Scholar
  9. Andersen AR, Friberg L, Olsen TS, Olesen J (1988) Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol 45 (2): 154-159 PubMedCrossRefGoogle Scholar
  10. Andreou AP, Goadsby PJ (2011) Topiramate in the treatment of migraine: A kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia 31 (13): 1343-1358 PubMedCrossRefGoogle Scholar
  11. Anttila P, Metsahonkala L, et al. (1999) School start and occurrence of headache. Pediatrics 103 (6): e80PubMedCrossRefGoogle Scholar
  12. Anttila P, Metsahonkala L, et al. (2000) Predisposing and provoking factors in childhood headache. Headache 40 (5): 351-356PubMedCrossRefGoogle Scholar
  13. Anttila P, Metsahonkala L, et al. (2001) Comorbidity of other pains in schoolchildren with migraine or nonmigrainous headache. J Pediatr 138 (2): 176-180PubMedCrossRefGoogle Scholar
  14. Anttila P, Metsahonkala L, et al. (2002) Muscle tenderness in pericranial and neck-shoulder region in children with headache. A controlled study. Cephalalgia 22 (5): 340-344PubMedCrossRefGoogle Scholar
  15. Anttila P, Metsahonkala L, et al. (2006) Long-term trends in the incidence of headache in Finnish schoolchildren. Pediatrics 117 (6): e1197 – e1201PubMedCrossRefGoogle Scholar
  16. Anttila V, Stefansson H et al. (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42 (10): 869-873 PubMedCrossRefGoogle Scholar
  17. Aoki K R (2003) Evidence for antinoceptive activity of botulinum toxin type A in pain management. Headache43: S9– S15PubMedCrossRefGoogle Scholar
  18. Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26 (5): 785-793 PubMedCrossRefGoogle Scholar
  19. Aretaeus Cappadociae (81131) De causis et signis acutorum et diuturnorum morborum. Liber Primus Oxford, 1723Google Scholar
  20. Aromaa M, Sillanpaa ML, et al. (1998) Childhood headache at school entry: a controlled clinical study. Neurology 50 (6): 1729-1736 PubMed Google Scholar
  21. Aromaa M, Sillanpaa ML, et al. (1993) Prevalence of frequent headache in young Finnish adults starting a family. Cephalalgia 13 (5): 330-337 PubMedCrossRefGoogle Scholar
  22. Aromaa M, Sillanpaa ML, et al. (2000) Pain experience of children with headache and their families: A controlled study. Pediatrics 106 (2 Pt 1): 270-275PubMedCrossRefGoogle Scholar
  23. Aromaa M, Rautava P, et al. (1996) Prepregnancy headache and the well-being of mother and newborn. Headache 36 (7): 409-415PubMedCrossRefGoogle Scholar
  24. Aromaa M, Rautava P, et al. (1998) Factors of early life as predictors of headache in children at school entry. Headache 38 (1): 23-30PubMedCrossRefGoogle Scholar
  25. Aromaa M, Rautava P, et al. (1999) Familial occurrence of headache. Cephalalgia 19 (Suppl 25): 49-52 PubMedGoogle Scholar
  26. Aurora SK, Dodick DW, Turkel CC et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30 (7): 793-803 PubMedCrossRefGoogle Scholar
  27. Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group (2007) Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache 47 (4): 486-499Google Scholar
  28. Aurora SK (2009) Spectrum of illness: understanding biological patterns and relationships in chronic migraine. Neurology 72 (5 Suppl): S8-S13PubMedCrossRefGoogle Scholar
  29. Aurora SK, Dodick DW, et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the doubleblind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30 (7): 793-803 PubMedCrossRefGoogle Scholar
  30. Bahra A, Matharu MS, et al. (2001) Brainstem activation specific to migraine headache. Lancet 357 (9261): 1016-1017 PubMedCrossRefGoogle Scholar
  31. Barrett CF, Van den Maagdenberg AM et al. (2008) Familial hemiplegic migraine. Adv Genet 63: 57-83 PubMedCrossRefGoogle Scholar
  32. Beasley RW, Clayton TO, Crane J, Lai CK, Montefort SR, Mutius E, Stewart AW; and the ISAAC Phase Three Study Group (2011) Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: international study of asthma and allergies in childhood phase three. Am J Respir Crit Care Med 183 (2): 171-178. Epub 2010 Aug 13. PubMed PMID: 20709817Google Scholar
  33. Benecke R, Heinze A, et al. (2011) Botulinum type a toxin complex for the relief of upper back myofascial pain syndrome: How do fixed-location injections compare with trigger point-focused injections? Pain MedGoogle Scholar
  34. Berilgen MS, Bulut S et al. (2005) Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 25 (11): 1048-1053PubMedCrossRefGoogle Scholar
  35. Bernsen HJ, Van de Vlasakker C et al. (1990) Basilar artery migraine stroke. Headache 30 (3): 142-144PubMedCrossRefGoogle Scholar
  36. Bertin L, Brion N, et al. (1999) A dose-defining study of sumatriptan suppositories in the acute treatment of migraine. Int J Clin Pract 53 (8): 593-598 PubMed Google Scholar
  37. Bigal ME, Rapoport AM, Tepper SJ, Sheftell FD, Lipton RB (2005) The classification of chronic daily headache in adolescents - a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache 45 (5): 582-589PubMedCrossRefGoogle Scholar
  38. Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB (2006) Field testing alternative criteria for chronic migraine. Cephalalgia 26 (4): 477-482 PubMedCrossRefGoogle Scholar
  39. Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71 (22): 1821-1828 PubMedCrossRefGoogle Scholar
  40. Bigal ME, Rapoport AM, et al. (2004) Transformed migraine and medication overuse in a tertiary headache center - clinical characteristics and treatment outcomes. Cephalalgia 24 (6): 483-490PubMedCrossRefGoogle Scholar
  41. Bigal ME, Serrano D, et al. (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71 (8): 559-566 PubMedCrossRefGoogle Scholar
  42. Bigal ME, Liberman JN, et al. (2006) Obesity and migraine: a population study. Neurology 66 (4): 545-550 PubMedCrossRefGoogle Scholar
  43. Bigal ME, Lipton RB et al. (2009) Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine. Cephalalgia 29 (11): 1188-1196 PubMedCrossRefGoogle Scholar
  44. Bigal ME, Kurth T, et al. (2009) Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 72 (21): 1864-1871 PubMedCrossRefGoogle Scholar
  45. Bigal ME, Sheftell F, et al. (2008) A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 48 (9): 1286-1293PubMedCrossRefGoogle Scholar
  46. Bille BS (1962) Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls. Acta Pediatr Suppl 136: 1-151PubMedGoogle Scholar
  47. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM (2000) Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123 (6): 669-676 PubMedCrossRefGoogle Scholar
  48. Bingel U, Evers S, Reister F, Ebinger F, Paulus W (2009) Treatment of migraines and idiopathic headache syndromes in pregnancy and lactation Guideline of the German Migraine and Headache Society. Neurology 28: 896–906Google Scholar
  49. Bingen H from (1180) Liber scivias. Wiesbaden Monastery Bolay H, Reuter U et al. (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8 (2): 136-142 Google Scholar
  50. Bousser MG (2004) Estrogens, migraine, and stroke. Stroke 35 (11 (Suppl 1): 2652-2656PubMedCrossRefGoogle Scholar
  51. Bousser MG, Welch KM (2005) Relation between migraine and stroke. Lancet Neurol 4 (9): 533-542 PubMedCrossRefGoogle Scholar
  52. Bousser MG, Conard J, et al. (2000) Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 20 (3): 155-156 PubMedCrossRefGoogle Scholar
  53. Bowing G, Zhou J, et al. (2010) Differences in Chinese diagnoses for migraine and tension-type headache: an analysis of the German acupuncture trials (GERAC) for headache. Cephalalgia 30 (2): 224-232 PubMedGoogle Scholar
  54. Brennan KC (2011) Turn down the lights !: An irritable occipital cortex in migraine without aura. Neurology 76 (3): 206-207 PubMedCrossRefGoogle Scholar
  55. Buring JE, Hebert P et al. (1995) Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 52 (2): 129-134 PubMedCrossRefGoogle Scholar
  56. Cairns, B. E. and P. Gazerani (2009) Sex – related differences in pain. Maturitas 63 (4): 292-296PubMedCrossRefGoogle Scholar
  57. Caro G, Getsios D, et al. (2001) Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis. Cephalalgia 21 (1): 12-19PubMedCrossRefGoogle Scholar
  58. Chasman DI, Schurks M, et al. (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43 (7): 695-698 PubMedCrossRefGoogle Scholar
  59. Chernyshev OY, Vein AM et al. (2001) Blood flow velocity and pulsatility index differences in patients with unilateral migraine. Headache 41 (7): 704-709PubMedCrossRefGoogle Scholar
  60. Christie S, Goebel H et al. (2003) Crossover comparison of efficiency and preference for rizatriptan 10 mg versus ergotamine / caffeine in migraine. Eur Neurol 49 (1): 20-29 PublicMedCrossRefGoogle Scholar
  61. Cole JW, Kittner SJ (2010) Meta-analysis of results from case control and cohort studies finds that migraine is associated with approximately twice the risk of ischaemic stroke. Evid Based Med 15 (6): 193-194 PubMedCrossRefGoogle Scholar
  62. Contag SA, Mertz HL, et al. (2009) Migraine during pregnancy: is it more than a headache? Nat Rev Neurol 5 (8): 449-456 PubMedCrossRefGoogle Scholar
  63. Couch JR (2011) Update on chronic daily headache. Curr Treat Options Neurol 13 (1): 41-55PubMedCrossRefGoogle Scholar
  64. Couch JR (2011) Update on chronic daily headache. Curr Treat Options Neurol 13 (1): 41-55.PubMedCrossRefGoogle Scholar
  65. Cummings M (2009) Model Project Acupuncture - a summary of the ART, ARC and GERAC trials. Acupunct Med 27 (1): 26-30 PubMedCrossRefGoogle Scholar
  66. Dahlof C (1997) Would any acute treatment for migraine demonstrate recurrence? Cephalalgia 17 (Suppl 17): 17-19; discussion 19-20 Google Scholar
  67. Dahlof C (2001) Clinical efficacy and tolerability of sumatriptan tablet and suppository in the acute treatment of migraine: a review of data from clinical trials. Cephalalgia 21 (Suppl 1): 9-12 PubMedGoogle Scholar
  68. Dahlof C (2003) Clinical applications of new therapeutic deliveries in migraine. Neurology 61 ((Suppl 4): S31-S34PubMedGoogle Scholar
  69. de Vries B, Frants RR, et al. (2009) Molecular genetics of migraine. Hum Genet 126 (1): 115-132 PubMedCrossRefGoogle Scholar
  70. Denuelle M, Noulloche N, et al. (2011) A PET study of photophobia during spontaneous migraine attacks. Neurology 76 (3): 213-218 PubMedCrossRefGoogle Scholar
  71. Dichgans M, Förderreuther S et al. (1998) The D2 receptor NcoI allele: absence of allelic association with migraine with aura. Neurology 51 (3): 928PubMedGoogle Scholar
  72. Dichgans M, Herzog J et al. (2005) 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology 64 (4): 608–613 Public Cross Ref Google Scholar
  73. Diener HC, Harrer JU (2010) Is migraine a dangerous disease? Neurology 74 (8): 622-623 PubMedCrossRefGoogle Scholar
  74. Diener HC, Kurth T (2005) Is migraine a risk factor for stroke? Neurology 64 (9): 1496-1497 PubMedCrossRefGoogle Scholar
  75. Diener HC, Weimar C (2006) Patent foramen ovale, migraine and stroke: no reason to intervene. Nat Clin Pract Cardiovasc Med 3 (4): 176-177 PubMedCrossRefGoogle Scholar
  76. Diener HC, Tfelt-Hansen P et al. (2001) The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial. Cephalalgia 21 (6): 672-679 PubMedCrossRefGoogle Scholar
  77. Diener HC, Eikermann A et al. (2004a) Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol 52 (1): 50-56 CrossRefGoogle Scholar
  78. Diener HC, Bussone G et al. (2004b) Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 24 (11): 947-954CrossRefGoogle Scholar
  79. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind , single-dose, placebo-controlled parallel group study. Cephalalgia 25 (10): 776-787